McNally N J
Br J Cancer. 1975 Nov;32(5):610-8. doi: 10.1038/bjc.1975.268.
A comparison has been made of the effects of the 2-nitroimidazole Ro-07-0582 on tumour growth delay after irradiation and tumour cell survival in vitro after irradiation in vivo. This compound has previously been shown to be a specific sensitizer of hypoxic cells. A dose of 1 mg/g body weight gave an enhancement ratio of 2-2 for both growth delay and cell survival in a system where high pressure oxygen has been shown to have no effect. However, while the hypoxic fraction in the tumour was estimated to be less then 10% from the growth delay curves, the survival curves gave a value in excess of 50%. This discrepancy probably reflects differences in the response of cells left in situ or removed and assayed in vitro.
对2-硝基咪唑Ro-07-0582在体内照射后对肿瘤生长延迟的影响以及体内照射后体外肿瘤细胞存活情况进行了比较。该化合物先前已被证明是缺氧细胞的特异性增敏剂。在高压氧已被证明无作用的系统中,1mg/g体重的剂量对生长延迟和细胞存活的增强比均为2.2。然而,虽然根据生长延迟曲线估计肿瘤中的缺氧部分小于10%,但存活曲线给出的值超过50%。这种差异可能反映了原位留存细胞或取出并在体外检测的细胞反应的差异。